Post-chemoradiation volumetric response predicts survival in newly diagnosed glioblastoma treated with radiation, temozolomide, and bevacizumab or placebo

Benjamin Ellingson; Lauren Abrey; Josep Garcia; Olivier Chinot; Wolfgang Wick; Frank Saran; Ryo Nishikawa; Roger Henriksson; Warren Mason; Robert Harris; Kevin Leu; Davis Woodworth; Arnav Mehta; Catalina Raymond; Ararat Chakhoyan; Whitney Pope; Timothy Cloughesy

doi:10.1093/neuonc/noy064

Journal Articles Neuro-Oncology Year : 2018

Post-chemoradiation volumetric response predicts survival in newly diagnosed glioblastoma treated with radiation, temozolomide, and bevacizumab or placebo

, , , (1) , (2) , , , , , , , , , , , ,

1
2

Benjamin Ellingson

Function : Author

Lauren Abrey

Function : Author

Josep Garcia

Function : Author

Olivier Chinot

Function : Author
PersonId : 172185
IdHAL : olivier-chinot
IdRef : 034791205

Institut de neurophysiopathologie

Wolfgang Wick

Function : Author
PersonId : 766695
ORCID : 0000-0002-6171-634X

Service d’Oncologie Médicale [Hôpital de la Timone - APHM]

Frank Saran

Function : Author

Ryo Nishikawa

Function : Author

Roger Henriksson

Function : Author

Warren Mason

Function : Author

Robert Harris

Function : Author
PersonId : 757674
ORCID : 0000-0002-4641-1425

Kevin Leu

Function : Author

Davis Woodworth

Function : Author

Arnav Mehta

Function : Author

Catalina Raymond

Function : Author

Ararat Chakhoyan

Function : Author

Whitney Pope

Function : Author

Timothy Cloughesy

Function : Author

Domains

Life Sciences [q-bio]

dominique figarella-branger : Connect in order to contact the contributor

https://hal-amu.archives-ouvertes.fr/hal-01858243

Submitted on : Monday, August 20, 2018-11:55:38 AM

Last modification on : Friday, March 24, 2023-2:53:08 PM

Dates and versions

hal-01858243 , version 1 (20-08-2018)

Identifiers

HAL Id : hal-01858243 , version 1
DOI : 10.1093/neuonc/noy064
PUBMEDCENTRAL : PMC6178278

Cite

Benjamin Ellingson, Lauren Abrey, Josep Garcia, Olivier Chinot, Wolfgang Wick, et al.. Post-chemoradiation volumetric response predicts survival in newly diagnosed glioblastoma treated with radiation, temozolomide, and bevacizumab or placebo. Neuro-Oncology, 2018, ⟨10.1093/neuonc/noy064⟩. ⟨hal-01858243⟩

Export

BibTeX TEI Dublin Core DC Terms EndNote Datacite

Collections

CNRS UNIV-AMU INP INP-GLIOME

33 View

0 Download

Post-chemoradiation volumetric response predicts survival in newly diagnosed glioblastoma treated with radiation, temozolomide, and bevacizumab or placebo

Domains

Dates and versions

Identifiers

Cite

Export

Collections

Altmetric

Share